Tiziana says KOL call ties Phase 2a foralumab data to years of expanded access resultsNov 9Clinical readoutforalumabTiziana Life Sciences LTDUpdated
Tiziana to join ACTRIMS-ECTRIMS meeting in Toronto on foralumab programsOct 21PublicationforalumabTiziana Life Sciences LTD
Tiziana doses last patient in Phase 2 Alzheimer's trial of intranasal foralumabOct 16Clinical readoutforalumabTiziana Life Sciences LTD
Tiziana Life Sciences seeks FDA orphan drug status for foralumab in MSASep 30Regulatory milestoneforalumabTiziana Life Sciences LTD
Tiziana doses first ALS patients with intranasal foralumab in BANYAN trialSep 28Trial updateforalumabTiziana Life Sciences LTD
Tiziana completes last patient visit in Phase 2a INFORM-MS foralumab trialSep 21Clinical readoutforalumabTiziana Life Sciences LTD
Tiziana presents BANYAN trial poster on intranasal foralumab in ALS at conferenceAug 24PublicationforalumabTiziana Life Sciences LTD
Tiziana registers Phase 2a "BANYAN" trial of nasal foralumab in ALSJul 7Trial updateforalumabTiziana Life Sciences LTD